A Phase Ib study of lenalidomide in combination with imatinib for adult patients with chronic myeloid leukaemia in second molecular remission
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2016
At a glance
- Drugs Imatinib (Primary) ; Lenalidomide (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions
- Acronyms LENI
- 11 Oct 2016 Planned initiation date changed from 9 Nov 2015 to 22 Mar 2016.
- 11 Oct 2016 Status changed from not yet recruiting to recruiting.
- 05 Jul 2016 New trial record